Broncel Marlena, Koziróg-Kołacińska Marzena, Andryskowski Grzegorz, Duchnowicz Piotr, Koter-Michalak Maria, Owczarczyk Aleksandra, Chojnowska-Jezierska Julita
Uniwersytet Medyczny w Łodzi, Klinika Chorób Wewnetrznych z Oddziałem Farmakologii Klinicznej i Terapii Monitorowanej.
Pol Merkur Lekarski. 2007 Aug;23(134):116-9.
To estimate the influence of anthocyanins from Aronia melanocarpa on blood pressure, concentration of endothelin-1 (ET-1), serum lipids, fasting glucose, uric acid and membrane cholesterol in erythrocytes of patients (pts) with metabolic syndrome (MS).
The study comprised 22 healthy volunteers and 25 pts with MS treated with anthocyanins (3 x 100 mg/d) for 2 months. Waist circumference (> or = 80 cm for women and > or =94 cm for men), triglicerydes (TG) level >150 mg/dl (1.7 mmol/l), cholesterol-HDL (HDL-C) level < 40 mg/dl (1.0 mmol/l) for men and <50 mg/dl (1.3 mmol/l) for women, systolic blood pressure (SBP) >130 mmHg and/or diastolic blood pressure (DBP) >85 mmHg were inclusion criteria for patients with MS. Before and after 2 months of treatment the following parameters were determined: SBP, DBP, serum lipids (total cholesterol--TC, cholesterol LDL--LDL-C, cholesterol HDL--HDL-C, TG--by enzymatic method), membrane cholesterol in erythrocytes (method of IIcy), ET-1 (immunoenzymatic method), fasting glucose level was (colorimetric method), uric acid (enzymatic--colorimetric method).
After two months therapy of anthocyanins from Aronia melanocarpa in comparison with baseline it was observed a significant decrease of: SBP (144.20 +/- 9.97 vs. 131.83 +/- 12.24 mmHg, p < 0.001) and DBP (87.20 +/- 9.9 vs. 82.13 +/- 10.33 mmHg, p < 0.05), TC (242.80 +/- 34.48 vs. 227.96 +/- 33.07 mg/dl, p < 0.001), LDL-C (158.71 +/- 35.78 vs. 146.21 +/- 34.63 mg/dl, p < 0.01), TG (215.92 +/- 63.61 vs. 187.58 +/- 90 mg/dl, p < 0.05), ET-1 (2.44 +/- 0.51 vs. 1.74 +/- 0.42 pg/ml, p < 0.001) and membrane cholesterol (4.85 +/- 0.65 vs. 2.81 +/- 0.54 mmol/Lpc, p < 0.001), uric acid and fasting blood glucose levels did not change significantly after study cessation.
The results of our study show that anthocyanins from Aronia melanocarpa may be of benefit to patients with MS as for as atherosclerosis prevention is concerned. It seems to result from anthocyanins influence on blood pressure, serum lipid and endothelin-1 level.
评估黑果腺肋花楸中的花青素对代谢综合征(MS)患者的血压、内皮素-1(ET-1)浓度、血脂、空腹血糖、尿酸及红细胞膜胆固醇的影响。
该研究纳入22名健康志愿者以及25名接受花青素治疗(每日3次,每次100毫克)2个月的MS患者。MS患者的纳入标准为:腰围(女性≥80厘米,男性≥94厘米)、甘油三酯(TG)水平>150毫克/分升(1.7毫摩尔/升)、胆固醇-HDL(HDL-C)水平男性<40毫克/分升(1.0毫摩尔/升)且女性<50毫克/分升(1.3毫摩尔/升)、收缩压(SBP)>130毫米汞柱和/或舒张压(DBP)>85毫米汞柱。在治疗2个月前后测定以下参数:SBP、DBP、血脂(总胆固醇-TC、胆固醇LDL-LDL-C、胆固醇HDL-HDL-C、TG-酶法)、红细胞膜胆固醇(IIcy法)、ET-1(免疫酶法)、空腹血糖水平(比色法)、尿酸(酶促-比色法)。
与基线相比,经黑果腺肋花楸花青素治疗2个月后,观察到以下指标显著降低:SBP(144.20±9.97对131.83±12.24毫米汞柱,p<0.001)和DBP(87.20±9.9对82.13±10.33毫米汞柱,p<0.05)、TC(242.80±34.48对227.96±33.07毫克/分升,p<0.001)LDL-C(158.71±35.78对146.21±34.63毫克/分升,p<0.01)、TG(215.92±63.61对187.58±90毫克/分升,p<0.05)、ET-1(2.44±0.51对1.74±0.42皮克/毫升,p<0.001)和膜胆固醇(4.85±0.65对2.81±0.54毫摩尔/升每细胞,p<0.001),研究结束后尿酸和空腹血糖水平无显著变化。
我们的研究结果表明,就预防动脉粥样硬化而言,黑果腺肋花楸中的花青素可能对MS患者有益。这似乎是由于花青素对血压、血脂和内皮素-1水平的影响所致。